– NASDAQ:APM

Founder-led company

stock price today

$1.29
+0.21
+19.45%
Financial Health
0
1
2
3
4
5
6
7
8
9

stock price monthly change

-76.16%
month

stock price quarterly change

-76.16%
quarter

stock price yearly change

-57.65%
year

key metrics

Market Cap
3.68M
Enterprise value
6.51M
P/E
-0.89
EV/Sales
5.22
EV/EBITDA
N/A
Price/Sales
5.66
Price/Book
0.31
PEG ratio
N/A
EPS
-3.67
Revenue
N/A
EBITDA
-25.70M
Income
-12.62M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-3188.35%
Oper. margin
-2890.36%
Gross margin
-24.31%
EBIT margin
-2890.36%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

stock price history

stock forecast

financial statements

(NASDAQ:APM): Profit margin
Jun 2022 527.46K -1.88M -357.42%
Dec 2022 768.42K -7.91M -1029.94%
Jun 2023 431.37K -5.48M -1271.99%
Dec 2023 0 2.66M
(NASDAQ:APM): Analyst Estimates
2025 65.7M 4.97M 7.57%
2026 106.8M 14.01M 13.12%
  • Analysts Price target

  • Financials & Ratios estimates

0%
Yield TTM
(NASDAQ:APM): Payout ratio
Payout ratio 0%
(NASDAQ:APM): Dividend Yield
2019
2020 0.98%
2021
2022
2023
(NASDAQ:APM): Debt to assets
Dec 2022 20867371 13.03M 62.46%
Feb 2023 0 0
Jun 2023 14412041 1.63M 11.33%
Dec 2023 20640091 5.25M 25.47%
(NASDAQ:APM): Cash Flow
Jun 2022 -6.80M 2.71M 3.02M
Dec 2022 -5.46M -266.56K 3.54M
Jun 2023 -6.24M 558.78K 1.14M
Dec 2023 -1.53M 65.98K 3.00M

alternative data

(NASDAQ:APM): Employee count
Aug 2023 18
Sep 2023 18
Oct 2023 18
Nov 2023 18
Dec 2023 18
Jan 2024 18
Feb 2024 18
Mar 2024 18
Apr 2024 18
May 2024 18
Jun 2024 3
Jul 2024 3

other data

0.55% -0.96%
of APM is owned by hedge funds
1.95K -51.78K
shares is hold by hedge funds
Insider Compensation
Mr. Chung Yuen Huen (1980) Founder, Chairman & Chief Executive Officer
$474,530
Dr. Clark Cheng (1980) Chief Medical Officer & Executive Director
$465,260
Dr. Wai Yip Lee (1974) Head of R&D
$405,200
Ms. Sabrina Khan (1982) Chief Financial Officer & Company Sec.
$372,540
Mr. Darren Lui (1981) Pres & Executive Director
$256,540
Friday, 20 December 2024
businesswire.com
Tuesday, 30 April 2024
businesswire.com
Wednesday, 6 March 2024
InvestorPlace
InvestorPlace
Monday, 8 May 2023
InvestorPlace
Wednesday, 3 May 2023
Proactive Investors
InvestorPlace
Friday, 2 September 2022
InvestorPlace
Thursday, 25 August 2022
Business Wire
Tuesday, 17 May 2022
Business Wire
Friday, 11 February 2022
Seeking Alpha
Thursday, 3 February 2022
PennyStocks
Tuesday, 25 January 2022
Pulse2
Thursday, 20 January 2022
Pulse2
Friday, 15 October 2021
Business Wire
Wednesday, 15 September 2021
Benzinga
  • What's the price of stock today?

    One share of  stock can currently be purchased for approximately $1.29.

  • When is 's next earnings date?

    Unfortunately, 's (APM) next earnings date is currently unknown.

  • Does pay dividends?

    No, does not pay dividends.

  • How much money does make?

    has a market capitalization of 3.68M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 66.71% to 431.38K US dollars.

  • What is 's stock symbol?

    null is traded on the NASDAQ under the ticker symbol "APM".

  • What is 's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of ?

    Shares of can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are 's key executives?

    's management team includes the following people:

    • Mr. Chung Yuen Huen Founder, Chairman & Chief Executive Officer(age: 45, pay: $474,530)
    • Dr. Clark Cheng Chief Medical Officer & Executive Director(age: 45, pay: $465,260)
    • Dr. Wai Yip Lee Head of R&D(age: 51, pay: $405,200)
    • Ms. Sabrina Khan Chief Financial Officer & Company Sec.(age: 43, pay: $372,540)
    • Mr. Darren Lui Pres & Executive Director(age: 44, pay: $256,540)
  • Is founder-led company?

    Yes, is a company led by its founder Mr. Chung Yuen Huen.

  • How many employees does have?

    As Jul 2024, employs 3 workers, which is 83% less then previous quarter.

  • When went public?

    null is publicly traded company for more then 6 years since IPO on 18 Dec 2018.

  • What is 's official website?

    The official website for is aptorumgroup.com.

  • How can i contact ?

    can be reached via phone at +44 20 8092 9299.

company profile:

Exchange:

NASDAQ

Full time employees:

3

Industry:

Biotechnology

Sector:

Healthcare

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.

17 Hanover Square
London, W1S 1BN

CIK: 0001734005
ISIN: KYG6096M1226
CUSIP: G6096M106